Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | TAS1553 |
Synonyms | |
Therapy Description |
TAS1553 inhibits the interaction of ribonuclease reductase (RNR) subunits, potentially resulting in reduced tumor growth (European Journal of Cancer, Volume 138, S58). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
TAS1553 | TAS 1553|TAS-1553 | TAS1553 inhibits the interaction of ribonuclease reductase (RNR) subunits, potentially resulting in reduced tumor growth (European Journal of Cancer, Volume 138, S58). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT04637009 | Phase I | TAS1553 | A Study of TAS1553 in Subjects With Relapsed or Refractory Acute Myeloid Leukemia (AML) and Other Myeloid Neoplasms | Terminated | USA | CAN | 0 |